The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal EGFR assessment in plasma and tissue samples in early non–small cell lung cancer (NSCLC).
 
Sara Torresan
No Relationships to Disclose
 
Alex Martinez-Marti
No Relationships to Disclose
 
Aina Arbusà Roca
No Relationships to Disclose
 
Augusto Valdivia
Honoraria - AZD (Inst); Janssen (Inst); Pfizer (Inst)
Consulting or Advisory Role - AMGEN
Travel, Accommodations, Expenses - AZD; TAKEDA
 
Patricia Iranzo Gomez
Honoraria - AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Merck Sharp & Dohme; Pfizer; Roche
 
Nuria Pardo
No Relationships to Disclose
 
Ilaria Priano
No Relationships to Disclose
 
Oriol Mirallas
Honoraria - Alimirall; Kyowa Kirin International; Recordati
Speakers' Bureau - ROVI; Sanofi
Research Funding - Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Almirall; Sanofi
 
Pedro Rocha
Travel, Accommodations, Expenses - AstraZeneca; BMS; Kyowa Kirin International; MSD; Roche
 
Susana Cedres Perez
Consulting or Advisory Role - Amphera; Bristol-Myers Squibb; MSD Oncology
Travel, Accommodations, Expenses - MSD Oncology; Roche/Genentech; Roche/Genentech
 
Irene Sansano
No Relationships to Disclose
 
Mara Cruellas
Honoraria - Roche
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Palex
 
Mireia Soleda
No Relationships to Disclose
 
Ana Vivancos
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; Gilead Sciences; GlaxoSmithKline; ITeos Therapeutics; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Turning Point Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; Bristol Myers Squibb; Daiichi Sankyo; Genentech; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Medical Trends; Medscape; Merck Serono; Merck Sharp & Dohme; Novartis; Peervoice; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche
Other Relationship - GRIFOLS
(OPTIONAL) Uncompensated Relationships - "ETOP IBCSG Partners" Member of the Scientific Committee; “Medical writing assistance for this abstract was provided by Nimisha H. Bhoola, PhD, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd.”; Member of the Scientific Advisory Committee -Hospital Universitari Parc Taulí-; SEOM (Sociedad Española de Oncología Médica), President from 2021-2023